into the left ventricle caused a 7-fold (4-13) increase in tumor vascular resistance (P < 0.01) and no significant increase of the vascular resistance of other organs. The change in tumor vascular resistance was not completely due to an increased level of circulating catecholamines because a 2-fold (1.6-3.4) increase in the resistance (P < 0.01) was seen when prostaglandin E, was injected into the left ventricle of animals pretreated with phenoxybenzamine. The prostaglandin E 2 -induced tumor vasoconstriction was not due to an increased level of circulating angiotensin II because in animals in which a and angiotensin receptors were blocked, prostaglandin E 2 increased the tumor vascular resistance by a factor of 3 (2.3-5.5) (P < 0.01). The tumor vasculature appears to be hypersensitive to a-receptor activation and responds to prostaglandin E 2 with vasoconstriction which cannot be accounted for by an increased level of circulating catecholamines or angiotensin II. In these experiments, the vasculature of the tumor responded to pharmacological agents in a manner that was not displayed by the vasculature of other organs. It may be possible to selectively control tumor blood flow without adversely affecting the blood flow to other organs of the host.
MOST CANCERS are found as solid tumors, and much research in the field of cancer is concerned with a description of the basic causes of tumor growth at the cellular level. A unique approach has been taken by Folkman 1 who has described the concept of angiogenesis in which the tumor forces the host to develop a new vasculature in order to supply nutrients to the tumor. Folkman has pointed out that solid tumors cannot grow unless the angiogenic responses are elicited.
In view of the great interest in cancer it is curious that fundamental information regarding the cardiovascular mechanisms responsible for the regulation of the tumor blood flow has not been obtained .In 1975, Gullino 2 stated that "Control of circulation in tumors is an open question, at present." There is undoubtedly a practical reason for this neglect. The vasculature of the tumor is ever changing and does not lend itself to precise anatomical description. The traditional methods used to measure blood flow to an organ are difficult to apply to tissues such as tumors which have a variable size and location. In recent years the microsphere method for the determination of regional blood flows has been validated in many laboratories. 3 ' 4 We have performed a series of experiments designed to explore the use of radioactive microspheres to measure tumor blood flow, and we have used this technique to test the hypothesis that the regulation of the tumor blood flow does not differ from that of normal tissue. This hypothesis was tested by observing the responses of the vasculature of the tumor and other organs of the rabbit to norepinephrine which is known to cause vasoconstriction. Prostaglandin E 2 also was used because it is known to have vasodilator activity in many organs 5 and to modify the vasoconstrictor actions of norepinephrine.
Methods
The tumor system employed in this study was the V-2 carcinoma which is an anaplastic vascular sarcoma. The tumor was passed by the intramuscular injection of approximately 0.5 ml of heavy cytosieve suspension in saline into each hindlimb of male, New Zealand white rabbits (mean weight, 2.25 ± 0.14 kg). The experiments were performed approximately 2 weeks after the injection of the cancer cells.
SURGICAL PREPARATION
Two weeks after the implantation of the tumor, the rabbits were anesthetized with pentobarbital 40 mg/kg, iv. Polyvinyl catheters (outside diameter, 1.20 mm; inside diameter, 0.73 mm) were placed in the left ventricle via the carotid artery and in a femoral artery. The catheters were filled with heparinized saline and secured to the skin on the back of the neck. All experiments were performed 24 hours after surgery with the awake rabbit sitting quietly in a restraining cage in the laboratory.
BASIC PROTOCOL
In each experiment the regional blood flows were measured by injecting approximately 200,000 microspheres (25 /AID; 3M Co.) into the left ventricle while simultaneously withdrawing an integrated arterial sample from the femoral catheter at a rate of 2.06 ml/min. The blood withdrawal continued for 60 seconds after the termination of the microsphere injection. This measurement was referred to as the control observation. A drug was then given via the left ventricular catheter and the regional blood flows were measured 1.5 minutes after the injection of the drug using microspheres bearing a different radioactive label . Microspheres labeled with  85 Sr,  125 I,  141 Ce, and   46 Sc were available and, in some animals, it was possible to repeat the control and treatment observation after a delay of 3 hours. The spheres were suspended in 10% dextran to reduce the rate of sedimentation. The spheres were flushed through the catheter with a following injection of 1 ml of 0.9% saline. The injection and withdrawal catheters and their contents were checked for residual radioactivity after the experiments. Less than 0.5% of the injected dose could be located in the left ventricular catheter and less than 1 % of the activity in the blood sample was found in the withdrawal system. The femoral arterial blood pressure was monitored with a Statham P23Db transducer. The blood pressure could not be monitored during the integrated arterial withdrawal, and the blood pressure associated with each microsphere injection was taken to be the mean of the pressures observed prior to the beginning of the withdrawal and that seen after the conclusion of the withdrawal.
The flow measurement was made 1.5 minutes after the injection of the drug because the microspheres would lodge in the tissue over a finite time period. The blood pressure associated with that flow determination was observed after the peak pressor response at a time when the rate of change of blood pressure was relatively small. At the end of the experiment, the rabbit was killed by intraventricular injection of pentobarbital (100 mg/kg) followed by saturated potassium chloride. The tumors were dissected free of the surrounding tissue, and the brain, kidneys, heart, and testes were removed. As the animals had a tumor on each hindlimb, the tumors from each animal were identified as to the side (right or left) on which that tumor was found. A strip of intestine from the duodenal region, a gastrocnemius muscle, and a piece of skin also were taken for assay. Each organ was weighed and cut into 2-g slices. Each slice was placed in a glass counting vial and the radioactivity was assayed in a Nuclear Chicago 1185 three-channel gamma counter. Appropriate corrections were made for the spillover of radioactive counts between channels. The counts per minute per microsphere at the time of assay were determined by counting a set of vials each containing a known nurnber of microspheres labeled with one of the radionuclides used in the study. In this way it was possible to calculate the number of microspheres in each piece of tissue. The blood flow to each piece of tissue was obtained by multiplying the number of spheres in that tissue by a flow factor. 4 The flow factor was equal to the withdrawal rate divided by the number of microspheres obtained in the integrated arterial blood sample. Full details of the procedures used for the tissue assay and data reduction are described elsewhere. 7 In our preparation, a blood flow of 1 ml/min was reflected in the trapping of approximately 500 microspheres with approximately 11,000 counts/min.
Protocols

NOREPINEPHRINE
The effect of norepinephrine was tested by injecting norepinephrine [50 /xg (Levophed, Winthrop)] into the left ventricle.
PROSTAGLANDIN E 2
The effect of prostaglandin E 2 was tested by injecting prostaglandin E 2 (50 /u.g) into the left ventricle.
These doses were selected because we previously had determined that they produced a maximum response. The use of a dose in the flat upper region of the dose response curve reduced the variation between animals that would have been seen had we worked in the steeply ascending portion of the curve.
a-RECEPTOR BLOCKADE
The responses of the tumor vasculature to the prostaglandin E 2 may have been due to the action of catecholamines. 6 This possibility was tested by pretreating the rabbits with phenoxybenzamine [10 mg (Smith, Kline, and French)] given via the left ventricular catheter 4 hours before the observations were made. The vascular responses to the intraventricular injection of prostaglandin E 2 (50 fig) were then measured as described in protocol 2.
ANGIOTENSIN RECEPTOR BLOCKADE
The responses to prostaglandin E^ may have been due to the secondary release of angiotensin II. This possibility was tested by pretreating the animals with phenoxybenza-mine as described above and then inducing angiotensin receptor blockade. Angiotensin receptor blockade was provided by infusing [Sar',Ue 8 ]angiotensin II (Beckman) into the jugular vein at a rate of 7 ju.g/min for 20 minutes. The control observation of regional blood flows was made 10 minutes after the initiation of the angiotensin receptor blockade. Prostaglandin E 2 (50 /u.g) then was injected into the left ventricle and the regional blood flows were measured 1.5 minutes later.
ANTIGENIC IMPLANT
The V-2 carcinoma is antigenic and causes an inflammatory response in the host. It was possible that we were observing the response of the inflammatory capsule rather than that of the tumor vasculature. This was tested by implanting a cotton wad enclosing foreign muscle tissue into the site normally used for the injection of the tumor cells. Two weeks after the implantation, the response of the inflammatory capsule to prostaglandin E 2 was determined as described in protocol 2.
STATISTICS
Comparisons between control and treatment observations of blood pressure and tumor blood flow per gram were made using the paired Mest. Comparisons between different protocols were made using the unpaired Mest. The mean value for blood flow per gram in the control and treatment condition was determined by dividing the total flow observed in that series by the total weight of tissue found in that series. The vascular resistance was determined by dividing the blood pressure appropriate to the observation by the blood flow per gram. Comparisons between the control and treatment resistance were made after logarithmic transformation because resistance is a ratio and, as such, is not normally distributed. 8 The results were expressed as a mean value followed by an indication of the variance of the data. Where no transformation was used, the symbol ± precedes the standard error of the mean. Where a logarithmic transformation was used, the mean value is followed by two numbers which indicate the 95% confidence interval. 8 
Results
The results of the experiments in which microspheres with diameters of 50 and 25 /xm were given simultaneously are shown in Table 1 . If the vascular channels in any organ were large enough to permit 25-/xm spheres to pass into the venous circulation, then the microsphere method would be invalid in that preparation. An index of this potential error can be obtained from the ratio of the blood flows as measured with 50-/xm spheres to that measured with 25-/j.m spheres when the spheres are injected simultaneously. It can be seen in Table 1 that, in the control condition, the 50-/xm/25-/xm flow ratios ranged from 0.88 to 1.2. The blood flows as measured with 50-^im spheres were not significantly different from the blood flows as measured with 25-^.m spheres in the tumor or in any organ. We conclude that significant numbers of 25-/u.m spheres do not pass through into the venous circulations of the tissues listed in Table 1 . It is possible that a small fraction of the 25-/u.m microspheres did pass through the circulations of the tumor and skin. The analysis of lung tissue yielded an average apparent flow per gram of 0.49 ± 0.38 ml/min with the 25-/j.m spheres and 0.29 ± 0.23 ml/min with the 50-/u.m spheres. This discrepancy indicates that some 25-ju.m spheres were crossing into the venous circulation. This would serve to underestimate the blood flow.
Many of the treatments appeared to produce profound vasoconstriction. This was determined by the fact that relatively few spheres were found after the application of those treatments. It is possible that the acquisition of relatively few spheres in a tissue reflects a strong vasodilation with the microspheres being shunted through the tissue into the venous circulation. In one rabbit, the simultaneous injection of 25-and 50-/u.m spheres after the injection of prostaglandin E 2 was performed to test this hypothesis. In this experiment, the flows as measured with 50-/i.m spheres were not different from the blood flows as measured with 25-/xm spheres. These data support the contention that the response to the drug was true vasoconstriction and that the results we have obtained are not artifacts due to massive vasodilation rendering the microsphere method inappropriate for this study.
The V-2 carcinomas were surrounded by an inflammatory capsule. The responses of a similar capsule were tested by measuring the blood flow to the region of embedded cotton and foreign tissue before and after the injection of prostaglandin E 2 . Eighteen observations were made in six rabbits. The tissue around the implant had an average weight of 1.46 ± 0.43 g and an average blood flow in the control condition of 0.225 ± 0.08 ml/min. The resistance of the tissue in the control condition was 738 (415-1,309), and the resistance observed after the injection of prostaglandin E 2 was 351 (190-521) (mm Hg x min)/(ml x g). The change in tissue resistance was significant (P < 0.01), and it was apparent that the capsule responded to prostaglandin E 2 with vasodilation. In a subsequent series of experiments, the vasculature of the V-2 carcinoma responded to prostaglandin E 2 with a strong vasoconstriction. We therefore conclude that we are indeed looking at the vasculature of the carcinoma itself and not observing the responses of the surrounding capsule.
The average number of spheres in the control blood samples was 1,122 ± 145, and the average number of spheres in the blood samples drawn after the injection of vasoactive agents was 914 ± 103. The average number of spheres in the tumor in the control condition was 734 ± 91. These data indicate that the number of spheres trapped in the tumors and found in the blood was sufficiently large as to satisfy the criteria of Buckberg et al. 9 The average number of spheres found in the tumor in the treatment condition ranged from 171 ± 30 in protocol 3 to 27 ± 8 in protocol 1. These numbers are too low to give an acceptably accurate estimate of the blood flow. Nevertheless it is obvious that, if there is to be a precipitous fall in blood flow, few spheres will be trapped. Our estimates of tumor blood flow after vasoconstriction have a relatively high variance but the mean values are sufficiently different from the control values as to indicate the degree of vasoconstriction that did occur. Fourteen tumors were examined in the protocol in which we found an average of 27 spheres per tumor. This series yielded a total of 378 spheres which provides a more accurate estimate of mean flow than does one observation of 27 spheres.
EFFECT OF NOREPINEPHRINE
The response of the V-2 carcinoma to norepinephrine is shown in Table 2 . Fourteen observations were made in four rabbits. One and one-half minutes after the injection of norepinephrine (50 /j.g), the mean blood pressure had returned to the control level of 83 ± 3.75 mm Hg. In the control condition, the tumor had a blood flow of 0.47 ± 0.12 (ml/min per gm) which fell to 0.01 ± 0.004 (ml/min per g) 1.5 minutes after the injection of norepinephrine. The resistance of the tumor in the control condition was 208 (124-352) [(mm Hg x min)/ml x g)]. The injection of norepinephrine (50 /*g) produced a 41-fold increase in tumor vascular resistance. No other organ showed such a sensitivity to exogenous norepinephrine. The vascular resistance of the muscle increased by a factor of 3.05 (1.9-9.7) and that of the kidneys by a factor of 3.00 (1.9-9.4).
PROSTAGLANDIN E,
The response of the vasculature of the V-2 carcinoma to the left ventricular injection of prostaglandin E 2 (50 fig) is shown in Table 3 . Fourteen observations were made in nine rabbits. One and one-half minutes after the injection of prostaglandin E 2 , the mean values for blood pressure and flow per gram had fallen and resistance had increased. The hypertension, ischemia, and increase in vascular resistance all were significant (P < 0.01). The ratio of the resistance of the tumor vasculature after the drug to that in the control condition was 7.34 (4.1-12.7). The significant vasoconstriction seen in the tumor vasculature after the injection of prostaglandin E 2 is in sharp contrast to the response of all other organs. The usual response of these organs was a vasodilation, and no significant vasoconstriction could be observed in any organ under the conditions of this experiment. The peak pressor responses seen after the injection of norepinephrine were approximately 10 mm Hg greater than those reported here. The lowest blood pressures seen after the injection of prostaglandin E 2 were approximately 10 mm Hg less than those reported here.
a-RECEPTOR BLOCKADE
The response of the vasculature of the tumors to prostaglandin E 2 was observed after a-receptor blockade (Table  4) . Sixteen observations were made in 12 rabbits. After the injection of prostaglandin E 2 , the blood pressure and blood flow fell and the resistance rose. The hypotension, ischemia, and increased resistance were all significant (P < 0.01). The injection of prostaglandin E 2 caused the resistance of the tumor to increase by a factor of 2.24 (1.6-3.4). In sharp contrast to this observation, we were not able to observe vasoconstriction in any other organ in this preparation.
The efficacy of the a-receptor blockade was tested and, under the conditions of the experiment, we could not obtain an increase in blood pressure after the injection of norepinephrine (5 /ig) in the phenoxybenzamine-treated animals, whereas the pressor response to this dose of norepinephrine was clearly evident in rabbits that had not been pretreated with phenoxybenzamine.
ANGIOTENSIN RECEPTOR BLOCKADE
The response of the vasculature of the tissues was observed after a-and angiotensin receptor blockade. Fifteen experiments were performed on nine rabbits (Table 5) . After the injection of prostaglandin E 2 into these preparations, the blood pressure and tumor blood flow fell and tumor vascular resistance increased. All of these changes were significant (P < 0.01). The injection of prostaglandin E 2 caused the resistance of the tumor vascular bed to increase by a factor of 3.62 (2.35-5.49). These results again were in sharp contrast to the responses of all other organs studied. We could demonstrate no significant degree of vasoconstriction in any other organ.
The efficacy of the angiotensin receptor blockade was tested with the injection of angiotensin II (300 ng) into the left ventricle. In normal rabbits, this procedure resulted in a marked elevation of blood pressure. No change in blood pressure was observed when angiotensin II was given 'during [Sar',Ile used external beta monitoring to measure the blood flow to the V-2 carcinoma in rabbits and reported the mean flow to be 0.3 (ml/min per g). Those observations were made on anesthetized rabbits and would be expected to be somewhat lower than the values we have observed in unanesthetized rabbits. There are very few data on the blood flow to other tumors. Gullino and Grantham" observed blood flows between 0.04 and 0.08 (ml/min per g) in several tumors. Rogers et al. 12 reported a value of 0.71 (ml/min per g) in hamster amelanotic melanoma. Edlich and Tookenay 13 measured the blood flow in the Katsumi carcinoma in the dog and report a value of 0.84 (ml/min per g). The value of 220-1,000 ml/min per g attributed to this report by Spencer 14 is due to an error by Edlich and Tookenay in labeling a graph. The control flows per gram that we have observed in our study are in the general range that is reported in the literature.
Several authors 2 -1Si 16 have observed that tumors are sensitive to catecholamines. In our experiments, we observed vasoconstriction in the tumor in response to an agent that causes vasoconstriction in other organs. Nevertheless, the magnitude of the response we observed is far greater than that of any other organ that we examined in the rabbit. We conclude that, whereas the V-2 carcinoma appears to contain a-receptors, as does the vasculature of most other organs, the sensitivity of the vasculature of the V-2 carcinoma to a-receptor stimulation is much greater than that of other organs.
We had previously observed that prostaglandin E^ produced hypotension in many species in our laboratory. It is VOL. 41, No. 4, OCTOBER 1977 well known that prostaglandin E 2 can cause vasodilation in many organs 5 , and for this reason we selected prostaglandin E 2 as the second pharmacologically active agent to be studied. The strong vasoconstriction in the tumor vasculature after prostaglandin E 2 administration was not seen in any other organ. This response is a clear departure from that which would have been predicted from the generally accepted concept in the field . 5 -6 If the tumor vasculature is to act in a manner similar to the vasculature of the host tissue, we would have expected either weak vasoconstriction or vasodilation in the tumor.
Because the tumor did not behave like any other tissue, the increase in resistance observed after the injection of prostaglandin E 2 might have been due to the secondary release of catecholamines in response to the hypotension or to an increased sensitivity to normal levels of catecholamines. The latter phenomenon has been observed by Malik and McGiff 7 in the vasculature of the rat kidney. We therefore pretreated the rabbits with phenoxybenzamine to "see whether prostaglandin E 2 -induced vasoconstriction would be observed. The vasoconstriction seen after the injection of prostaglandin E 2 was much less pronounced in the rabbits pretreated with phenoxybenzamine than it was in the normal rabbits. Nevertheless, prostaglandin E 2 caused a vasoconstriction of the tumor vasculature in the phenoxybenzamine-treated rabbits, in which we observed a doubling of the tumor vascular resistance. This also is a response which is different from that seen in any other organ and is not in accord with generally accepted concepts. 5 -l6 The vasculature of the tumor did not behave like the vasculature of the host tissue nor like that of any other organ that we observed in the rabbit.
It was possible that the cardiovascular changes induced by prostaglandin E 2 may have increased the level of circulating angiotensin II. Had this occurred, then the prostaglandin E 2 -induced vasoconstriction in the rabbits with areceptor blockade may have been due to an increased level of angiotensin II. This hypothesis was tested in the fourth protocol in which angiotensin receptor blockade was included with a-receptor blockade. Prostaglandin E 2 caused the resistance of the tumor vasculature to increase 3-fold in these preparations. These responses were not significantly different from the responses observed after a-receptor blockade alone, and we conclude that the response of the tumor vasculature to prostaglandin E 2 is not due to the changing levels of circulating angiotensin II.
Our results have some relevance to the recent report of Santoro et al. 17 -18 These authors have shown that daily injections of 5 /xg of an analogue of prostaglandin E 2 inhibited the growth of the B-16 melanoma in mice. The tumors in the treated group were only 30% of the weight of the tumors in the control group. It is possible that some of this growth inhibition may have been secondary to ischemia induced by the prostaglandin E 2 .
The fact that there was no significant difference between the control flow per gram observed in any protocol indicates that in the unanesthetized rabbit there is minimal aor angiotensin receptor activity in the tumor vasculature. This conclusion is based on the observation that the control flow per gram did not significantly change after areceptor blockade or after angiotensin receptor blockade.
Another interesting point is that the tumor vasculature did not respond to vasoactive agents in the same way as did the vasculature of the other organs studied. The tumor vasculature was hypersensitive to a-receptor stimulation and responded to prostaglandin E 2 with vasoconstriction. We could not find any other organ in the rabbit which had these two characteristics. These unique features are of interest because a tumor cannot grow unless it can maintain a vasculature which provides the nutrients on which it feeds. The potential for inhibiting tumor growth by inducing vasoconstriction in the tumor becomes attractive only if it is possible to induce selective vasoconstriction in the tumor without causing cardiovascular changes in other organs which may compromise the life of the host. The results of these experiments indicates that there may be sufficient differences between the responsiveness of the tumor vasculature and that of other organs to permit the flow to the tumor to be manipulated selectively.
